Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Clonal Cytopenia of Undetermined Significance · Myelodysplastic Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Amber Afzal, M.D., MSCI) · afzalamber@wustl.edu · 314-273-0564
    Contact: Principal Investigator (Amber Afzal, M.D., MSCI)
    Meagan Jacoby, M.D., Ph.D. (Sub-investigator)
    Matthew Walter, M.D. (Sub-investigator)
    Feng Gao, Ph.D. (Sub-investigator)
Study leads
  • Amber Afzal, M.D., MSCI

    Principal Investigator

    Washington University School of Medicine